Investing in a Resilient and Sustainable Future
A global investor headquartered in Singapore since 1991
Impact
Learn how investments help transform industries and uplift lives
Talent
Discover opportunities with our portfolio companies
Empowering Tech Innovators & Future Leaders
Portfolio Spotlight Ep 5: Endowus with Co-Founder, Chairman and Group CIO, Samuel Rhee
In the dynamic landscape of Southeast Asia’s fintech sector, one company stands out for its unwavering commitment to financial…
Circles – Reshaping the Telco industry from Singapore to the World
The telecommunications industry is undergoing significant transformation, driven by rapid technological advancements such as generative artificial intelligence, expansion of…
Portfolio Spotlight Ep 4: AlphaSense with APAC Regional Director, Mark Leadercramer
We’re back with another Portfolio Spotlight, this time on AlphaSense— a cutting-edge market intelligence and search platform powered by…
Portfolio Spotlight Ep 3: Gradiant – Turning the Tide with Wastewater
(Photo of Gradiant’s Co-Founder & COO, Prakash Govindan, Co-Founder and CEO, Anurag Bajpayee, President, Govind Alagappan, from left to…
Portfolio Spotlight Ep 2: Doctor Anywhere with Founder & CEO, Wai Mun Lim
Did you know Doctor Anywhere, Singapore’s leading telemedicine provider, began with only 4 employees in 2017? ⏩ Fast forward…
Revolutionising Insurtech: Rob Schimek, CEO of Bolttech, on the Power of Connection
With operations in over 30 markets across four continents, bolttech is making significant waves in the insurance sector. Rob…
Latest News
Multiplier Holdings Launches With $27.5 Million in Funding to Accelerate the AI Journey for Professional Services Firms
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.
- 23 06 2025
- |
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.
- 05 06 2025
- |
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.
- 03 06 2025
- |
